Prasugrel versus Clopidogrel in Patients with Acute Coronary SyndromesStephen D. Wiviott, Elliott M. Antman, Eugene Braunwald et al.|New England Journal of Medicine|2007Cited by 6.7k
Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesStephen D. Wiviott, Marc S. Sabatine, Itamar Raz et al.|New England Journal of Medicine|2018Cited by 6.3k
Rivaroxaban in Patients with a Recent Acute Coronary SyndromeJessica L. Mega, C. Michael Gibson, Eugene Braunwald et al.|New England Journal of Medicine|2011Cited by 1.9k
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular EventsMarc S. Sabatine, Evan A. Stein, Robert P. Giugliano et al.|New England Journal of Medicine|2015Cited by 1.5k
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trialGilles Montalescot, Elliott M. Antman, Stephen D. Wiviott et al.|The Lancet|2009Cited by 1.1k